摘要
目的观察玻璃体切除硅油填充术联合超声乳化白内障摘除人工晶状体植入术治疗增生性糖尿病视网膜病变的临床疗效。方法根据患者自愿原则，将53例（57只眼）增生性糖尿病视网膜病变Ⅵ期患者分成联合手术组和玻璃体手术组。联合手术组33例（33只眼），单纯玻璃体手术组20例（24只眼）。联合手术组进行玻璃体视网膜手术、硅油填充、超声乳化白内障摘除及折叠型人工晶状体植入术，单纯玻璃体手术组进行玻璃体视网膜手术及硅油填充。对两组术后视网膜复位情况和并发症进行对照分析。结果联合手术组视网膜完全复位29只眼，视网膜复位率为87．9％；单纯玻璃体手术组视网膜完全复位20只眼，视网膜复位率为83．3％，两组比较差异无统计学意义（P=0．626）。联合手术组发生虹膜新生血管1只眼（3．0％），单纯玻璃体手术组发生虹膜新生血管2只眼（8．3％）。均发生在视网膜未复位的患者，两组比较差异无统计学意义（P=0．775）。结论玻璃体视网膜手术联合超声乳化白内障摘除人工晶状体植入术治疗增生性糖尿病视网膜病变安全有效，联合手术可避免再次行白内障手术。
Objective To determine clinieal outeomes of vitreetomy and silieone oil tamponade combined with phacoemulsification and foldable intraccular lens （IOL） implantation for the treatment of severe proliferative diabetic retinopathy （PDR）. Methods Fifty-three patients （57 eyes） with proliferative diabetic retinopathy were included in this study. All patients had tractional or traetional-rhegmatogenons retinal detachment. These patients were divided into combined surgery group and vitrectomy group. Thirtythree patients （33 eyes ）of combined surgery group underwent vitreoretinal surgery and silicone oil tamponade combined with phaeoemnlsifieation and foldable intraocnlar implantation. Twenty patients （24 eyes） of vitrectomy group underwent vitrcoretinal surgery and silicone oil tamponade only. The postoperative rates of retinal reattaehment and complications were analyzed. Results Rates of retinal reattachment in combined surgery group was 87. 9% vs. 83. 3% for vitreetomy groups. The difference in rates of retinal reattaehment was not statistically significant between these 2 groups （ P 〉 0. 05 ）. Rates of visual acuity better than 0. 1 in combined surgery group was 60. 6% vs. 33.3% in vitrectomy group 6 month after operation. The difference in rates of postoperative iris neovasenlarization was not statistically significant between these 2 groups （P 〉 0. 05 ）. Conclusions Combined vitreoretinal surgery and phaeoemnlsifieation with intraocular lens implantation is safe and effective in treating severe proliferative diabetic retinopathy. Combined surgery may prevent a second operation for postvitreetomy cataract, allowing earlier visual rehabilitation.
出处
《中华眼科杂志》
CAS
CSCD
北大核心
2007年第4期346-349,共4页
Chinese Journal of Ophthalmology
